Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ·Healthcare·Biotechnology
$4.59
+6.56%
Mkt Cap $7.91M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$4.00
Range $1.00 – $7.00
Implied Upside
-12.9%
Consensus $4.00 vs current $4.59
NASDAQ·Healthcare·Biotechnology
$4.59
+6.56%
Mkt Cap $7.91M
No recent rating data.
Price Target (2 analysts)
$4.00
Range $1.00 – $7.00
-12.9%
Consensus $4.00 vs current $4.59